In the world of genomic medicine, the CRISPR/Cas9 system is the ultimate "molecular scissor." However, even the sharpest tool is ineffective if it cannot reach its target. For researchers tackling complex diseases like lung tumors, the challenge has always been delivery.

To address this bottleneck, Creative Biolabs is hosting an exclusive webinar: "Optimization of Lipid Nanoparticles for CRISPR/Cas9 Delivery: Strategies to Enhance Gene Editing in Lung Tumor Models."

Why LNP Optimization is the Key

Lipid Nanoparticles (LNPs) have revolutionized the delivery of nucleic acids, as seen in the success of mRNA vaccines. Yet, delivering CRISPR components to lung tumors requires a higher level of sophistication. Factors such as endosomal escape, tissue-specific targeting, and serum stability are all dictated by the precise chemical architecture of the LNP.

Small adjustments in the molar ratios of ionizable lipids, helper lipids, and PEG-lipids can mean the difference between clinical success and therapeutic failure.

What You Will Learn

This webinar dives deep into the engineering strategies used to bypass biological barriers. Key highlights include:

Custom Formulation: How to tailor LNP compositions specifically for large CRISPR/Cas9 mRNA and sgRNA payloads.

Targeting Lung Microenvironments: Innovative chemical modifications that prioritize LNP accumulation in lung tissues.

In Vivo Performance: Real-world data demonstrating enhanced gene editing efficiency in lung tumor models.

Scalability & Stability: Transitioning from benchtop formulations to clinical-grade production.

Join the Discussion

Whether you are a molecular biologist, a formulation scientist, or a drug developer, this session will provide actionable insights into the future of non-viral delivery systems. Stay ahead of the curve and learn how to optimize your delivery platform for maximum impact.

Reserve your spot today by clicking the link below:

Register Now: Optimization of Lipid Nanoparticles for CRISPR/Cas9 Delivery

Webinar at a Glance

Topic: Optimization of Lipid Nanoparticles for CRISPR/Cas9 Delivery

Date: May 19, 2026

Speaker: Leading Scientists from Creative Biolabs

Cost: Free Registration

Meet Our Expert Speaker

We are honored to host Dr. Simone Pinto Carneiro, a distinguished pharmacist and Group Leader at LMU Munich. With over a decade of expertise in RNA-lipid nanoparticle engineering, Dr. Carneiro has been at the forefront of developing non-viral delivery strategies for pulmonary diseases. In this session, she will share her team's pioneering research on optimizing LNPs to specifically target KRAS mutations in lung cancer models, offering a rare look at the data driving the next generation of gene therapies.